While competitors take months to respond to FDA and other health authority label changes, trial updates, or safety issues, the Basil Intel platform auto-generates compliance-ready commercial competitive intelligence in minutes – giving your commercial team the edge when it matters most.
AI-powered landscape reports that continuously monitor every asset in a therapeutic class – delivering accurate, always-current competitive summaries built on the most frequently updated pharmaceutical dataset available. Easily export and share reports across your commercial teams.
Instantly surface where competing products converge – shared indications, overlapping claims, and similar safety profiles – so your teams know exactly where the class aligns.
Pinpoint the differences that drive prescribing decisions: unique efficacy data, distinct patient populations, and exclusive label claims that set each asset apart.
Continuous monitoring of FDA, EMA, and other health authority label changes, clinical trial initiations and results, safety signals, and regulatory guidance updates across all therapeutic areas.
Hourly data updates ensure your team knows about competitive moves within hours – not weeks. Customizable alerts deliver only the intelligence that matters to your specific products and markets.
Transform competitive response from a fire drill into a strategic advantage. React to market changes before they impact your revenue.
Pre-drafted promotional content built on validated regulatory data with full source citations and audit trails. "Inform, don't interpret" methodology ensures compliance.
Reduces MLR review cycles by up to 57% by providing compliance-ready drafts. Every claim links directly to its regulatory source document.
Get your messaging to market while the story is still relevant. Stop watching opportunities expire in approval queues.
Seamless integration with Veeva CRM, Salesforce, and other enterprise platforms. Push intelligence directly to the systems your teams already use.
Zero login fatigue – intelligence appears where reps work. No new systems to learn, no workflow disruption.
Maximize adoption and ensure competitive intelligence actually reaches the field, driving measurable impact on sales outcomes.
When a competitor initiated a clinical trial with pediatric inclusion criteria, Basil detected the ClinicalTrials.gov posting within hours and auto-generated a side-by-side endpoint comparison against our client's adult-only label. The sales team received validated competitive positioning before the competitor's press release – enabling proactive physician conversations that protected market share during a critical launch window.
"Basil identified the competitive threat before anyone on our team. By the time the competitor announced, our reps were in front of physicians with the full story."
VP, Sales Operations
Top 20 Pharma
